Mathew P. Martin

2.9k total citations
35 papers, 1.6k citations indexed

About

Mathew P. Martin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mathew P. Martin has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Mathew P. Martin's work include Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (10 papers) and Computational Drug Discovery Methods (6 papers). Mathew P. Martin is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Microtubule and mitosis dynamics (10 papers) and Computational Drug Discovery Methods (6 papers). Mathew P. Martin collaborates with scholars based in United Kingdom, United States and France. Mathew P. Martin's co-authors include E. Schönbrunn, Gunda I. Georg, S.H. Olesen, M.E.M. Noble, Jane Endicott, J. Zhu, S. Korolchuk, Saı̈d M. Sebti, S. Betzi and Roberta Pireddu and has published in prestigious journals such as Nature Communications, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Mathew P. Martin

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathew P. Martin United Kingdom	19	1.1k	499	311	277	273	35	1.6k
Bi‐Ching Sang United States	18	1.2k 1.1×	711 1.4×	337 1.1×	221 0.8×	167 0.6×	30	2.2k
Christian Grütter Germany	25	1.4k 1.2×	400 0.8×	483 1.6×	94 0.3×	301 1.1×	30	2.0k
Kamil Paruch Czechia	22	891 0.8×	611 1.2×	507 1.6×	185 0.7×	123 0.5×	52	1.7k
Joseph Schoepfer Switzerland	24	1.5k 1.4×	470 0.9×	532 1.7×	111 0.4×	209 0.8×	43	2.0k
Fleur M. Ferguson United States	16	1.3k 1.2×	394 0.8×	210 0.7×	132 0.5×	137 0.5×	33	1.7k
Swen Hoelder United Kingdom	16	1.1k 1.0×	246 0.5×	390 1.3×	162 0.6×	242 0.9×	22	1.5k
Yanke Liang United States	16	1.3k 1.2×	646 1.3×	181 0.6×	125 0.5×	86 0.3×	23	1.7k
J.M. Ostrem United States	6	1.9k 1.7×	818 1.6×	254 0.8×	210 0.8×	207 0.8×	8	2.4k
Daniella Zheleva United Kingdom	23	1.5k 1.4×	830 1.7×	220 0.7×	473 1.7×	92 0.3×	56	2.2k
Lian‐Sheng Li United States	19	1.4k 1.2×	557 1.1×	314 1.0×	127 0.5×	104 0.4×	49	1.9k

Countries citing papers authored by Mathew P. Martin

Since Specialization

Citations

This map shows the geographic impact of Mathew P. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew P. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew P. Martin more than expected).

Fields of papers citing papers by Mathew P. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew P. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew P. Martin. The network helps show where Mathew P. Martin may publish in the future.

Co-authorship network of co-authors of Mathew P. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew P. Martin. A scholar is included among the top collaborators of Mathew P. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew P. Martin. Mathew P. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Mathew P., et al.. (2025). Different applications and differentiated libraries for crystallographic fragment screening. Current Opinion in Structural Biology. 90. 102982–102982. 1 indexed citations

Martin, Mathew P., Ziwei Jiang, Michael J. Waring, et al.. (2025). Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction. Structure. 33(11). 1971–1983.e3. 1 indexed citations

Miller, Duncan C., et al.. (2023). Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy. Journal of Medicinal Chemistry. 66(7). 4491–4502. 15 indexed citations

George, Amy L., et al.. (2023). Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling. Journal of Proteome Research. 22(8). 2629–2640. 24 indexed citations

Davison, Jack R., Mathew P. Martin, Susan J. Tudhope, et al.. (2023). Fragment expansion with NUDELs – poised DNA-encoded libraries. Chemical Science. 14(31). 8288–8294. 8 indexed citations

Stewart, Hannah L., Marta Bon, Corinne Wills, et al.. (2023). Conformational study into N-alkyl-N′-aryl ureas to inform drug discovery. Bioorganic & Medicinal Chemistry. 91. 117387–117387. 2 indexed citations

Martin, Mathew P., Jane Endicott, M.E.M. Noble, & Natalie J. Tatum. (2023). Crystallographic fragment screening in academic cancer drug discovery. Methods in enzymology on CD-ROM/Methods in enzymology. 690. 211–234. 2 indexed citations

Marín‐Rubio, José Luis, Rachel E. Heap, María Emilia Dueñas, et al.. (2022). A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 65(18). 12014–12030. 7 indexed citations

Martin, Mathew P. & M.E.M. Noble. (2022). Exiting the tunnel of uncertainty: crystal soak to validated hit. Acta Crystallographica Section D Structural Biology. 78(11). 1294–1302. 4 indexed citations

10.

Tucker, Julie A. & Mathew P. Martin. (2021). Recent Advances in Kinase Drug Discovery Part I: The Editors’ Take. International Journal of Molecular Sciences. 22(14). 7560–7560. 2 indexed citations

11.

Miller, Duncan C., Mathew P. Martin, Santosh Adhikari, et al.. (2018). Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach. Organic & Biomolecular Chemistry. 16(11). 1843–1850. 12 indexed citations

12.

Martin, Mathew P., Jane Endicott, & M.E.M. Noble. (2017). Structure-based discovery of cyclin-dependent protein kinase inhibitors. Essays in Biochemistry. 61(5). 439–452. 42 indexed citations

13.

Zhu, J., Rebecca A. D. Cuellar, Norbert Berndt, et al.. (2017). Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors. Journal of Medicinal Chemistry. 60(18). 7863–7875. 76 indexed citations

14.

Brown, Nicholas R., S. Korolchuk, Mathew P. Martin, et al.. (2015). CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. Nature Communications. 6(1). 6769–6769. 161 indexed citations

15.

Martin, Mathew P., David Staunton, Matthis Geitmann, et al.. (2015). Identification and Characterization of an Irreversible Inhibitor of CDK2. Chemistry & Biology. 22(9). 1159–1164. 95 indexed citations

16.

Olesen, S.H., Donna J. Ingles, Jin-Yi Zhu, et al.. (2015). Stability of the Human Hsp90-p50Cdc37 Chaperone Complex against Nucleotides and Hsp90 Inhibitors, and the Influence of Phosphorylation by Casein Kinase 2. Molecules. 20(1). 1643–1660. 12 indexed citations

17.

Ember, S.W., Jin-Yi Zhu, S.H. Olesen, et al.. (2014). Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors. ACS Chemical Biology. 9(5). 1160–1171. 174 indexed citations

18.

Pireddu, Roberta, Ying Sun, Nan Sun, et al.. (2012). RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer. Cancer Research. 72(19). 5025–5034. 123 indexed citations

19.

Martin, Mathew P., et al.. (2012). A Novel Approach to the Discovery of Small‐Molecule Ligands of CDK2. ChemBioChem. 13(14). 2128–2136. 69 indexed citations

20.

Pireddu, Roberta, Mathew P. Martin, Shen‐Shu Sung, et al.. (2012). Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). MedChemComm. 3(6). 699–699. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact